Published in Appl Biochem Biotechnol on June 01, 1986
Y chromosome sequence variation and the history of human populations. Nat Genet (2000) 8.34
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. BMJ (2001) 2.74
Construction of human Y-chromosomal haplotypes using a new polymorphic A to G transition. Hum Mol Genet (1994) 2.47
Diet, antioxidant status, and smoking habits in French men. Am J Clin Nutr (1998) 2.41
ParaSight-F test for the detection of treatment failure in multidrug resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1996) 2.13
A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res (1999) 2.13
Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci (2000) 1.71
SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol (2001) 1.68
Selective enhancement of gene transfer by steroid-mediated gene delivery. Nat Biotechnol (2001) 1.63
Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res (1995) 1.55
Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Hum Genet (2000) 1.53
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Evidence for population level declines in adult HIV prevalence in Kenya. Sex Transm Infect (2006) 1.46
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population. Oncogene (2008) 1.46
The importance of finger clubbing in pulmonary tuberculosis. Tubercle (1979) 1.45
A view of modern human origins from Y chromosome microsatellite variation. Genome Res (1999) 1.45
Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem (1991) 1.42
Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem (1975) 1.39
A case of extreme negative intrathoracic pressure. Eur J Cardiothorac Surg (1998) 1.39
An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet (1990) 1.36
The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol (1991) 1.35
Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg (1990) 1.35
Scleral melting 16 years after pterygium excision with topical Mitomycin C adjuvant therapy. Cont Lens Anterior Eye (2006) 1.33
Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens (1998) 1.29
VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab (2006) 1.29
Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J Control Release (1998) 1.28
Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med (2001) 1.26
gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med (1998) 1.26
Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain (2000) 1.25
Simple method for retrieval of distal segment of the broken interlocking intramedullary nail. Injury (1999) 1.24
Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging (2000) 1.24
Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin Chem (1995) 1.24
Allele frequency distribution of the (TG)n(AG)m microsatellite in the apolipoprotein C-II gene. Genomics (1992) 1.20
Familial aggregation of blood pressure. Preliminary report. JAMA (1966) 1.18
Total bone and liver alkaline phosphatases in plasma: biological variations and reference limits. Clin Chem (1983) 1.16
A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients. Eur J Clin Pharmacol (1997) 1.14
UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem Pharmacol (1983) 1.14
Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer's patients. J Neurochem (1998) 1.11
Pathogenesis of cancrum oris (noma): confounding interactions of malnutrition with infection. Am J Trop Med Hyg (1999) 1.10
Surface activity and emulsification properties of hydrophobically modified dextrans. J Colloid Interface Sci (2002) 1.07
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis (2000) 1.06
Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain. Neuroscience (2004) 1.05
Need for revisiting the concept of reference values. Clin Chem Lab Med (2000) 1.04
Subcellular distribution of cytochrome P-450 in the brain. Brain Res (1986) 1.04
Dietary intakes, eating style and overweight in the Stanislas Family Study. Int J Obes Relat Metab Disord (2000) 1.03
Wine, beer, and mortality in middle-aged men from eastern France. Arch Intern Med (1999) 1.03
Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem (1988) 1.03
Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem (1993) 1.03
Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J Biomed Mater Res (1998) 1.02
A multilocus genotyping assay for cardiovascular disease. Clin Chem Lab Med (1998) 1.01
Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Res Brain Res Rev (1991) 1.01
Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers. Eur J Pharm Biopharm (2001) 1.01
Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum. Brain Res (1999) 1.01
Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release (1999) 1.00
Sarcoidosis in the western region of Saudi Arabia. Sarcoidosis Vasc Diffuse Lung Dis (1999) 1.00
Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis (1992) 1.00
Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. Southeast Asian J Trop Med Public Health (1996) 0.99
Hydrophobically modified alginate hydrogels as protein carriers with specific controlled release properties. J Control Release (2004) 0.99
RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. J Endocrinol Invest (2008) 0.99
Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. J Control Release (1999) 0.99
Surgical treatment of congenital dilatation of the bile duct with special reference to late complications after total excisional operation. J Pediatr Surg (1990) 0.99
Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol (1993) 0.98
Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol (2012) 0.98
Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem (1994) 0.98
High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med (2000) 0.98
Chromatographic separation of neodymium isotopes by using chemical exchange process. J Chromatogr A (2011) 0.98
Very high DDT-resistant population of Anopheles pharoensis Theobald (Diptera: Culicidae) from Gorgora, northern Ethiopia. Parasite (2006) 0.98
Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum Genet (1998) 0.98
Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet (2001) 0.97
Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr (1994) 0.97
Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging (2001) 0.97
Sodium alginate sponges with or without sodium hyaluronate: in vitro engineering of cartilage. J Biomed Mater Res (2001) 0.97
Clinical experience with an optical access trocar in gynecological laparoscopy-pelviscopy. JSLS (1999) 0.96
Expression of multiple gamma-glutamyltransferase genes in man. Biochem J (1994) 0.96
High incidence of rickets in children with wheezy bronchitis in a developing country. J R Soc Med (1982) 0.96
Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study. Gerontology (1990) 0.95
An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet (1989) 0.95
PDGF-alpha receptor and myelin basic protein mRNAs are not coexpressed by oligodendrocytes in vivo: a double in situ hybridization study in the anterior medullary velum of the neonatal rat. Mol Cell Neurosci (1997) 0.94
Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol (1998) 0.94
Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study. Int J Obes (Lond) (2008) 0.94
Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem (1998) 0.93
Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem Pharmacol (1992) 0.93
In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharmacol Exp Ther (1992) 0.92
Relations between reported alcohol consumption and certain biological variables in an "unselected" population. Clin Chem (1979) 0.92
Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake. Mol Psychiatry (2001) 0.92
Biochemical subtypes of oligodendrocyte in the anterior medullary velum of the rat as revealed by the monoclonal antibody Rip. Glia (1995) 0.91
Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study. Biochim Biophys Acta (2000) 0.91
Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels. Genet Epidemiol (1996) 0.91
ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy. Clin Chim Acta (1986) 0.90
Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett (1998) 0.90
An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism. Ann Biol Clin (Paris) (1986) 0.89
Comparison of cytochrome P-450 content and activities in liver microsomes of seven animal species, including man. Xenobiotica (1986) 0.89
Interaction of a macromolecular polyanion, dextran sulfate, with human hemoglobin. FEBS Lett (1986) 0.89
Capillaria philippinensis: an emerging parasite causing severe diarrhoea in Egypt. J Egypt Soc Parasitol (1999) 0.89
Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization (1): dextran-based surfactants. Colloids Surf B Biointerfaces (2008) 0.89
The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis. FEBS Lett (1994) 0.89
Gamma-glutamyltransferase: nucleotide sequence of the human pancreatic cDNA. Evidence for a ubiquitous gamma-glutamyltransferase polypeptide in human tissues. Biochem Pharmacol (1992) 0.89
Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig. Biomaterials (2000) 0.88
Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release (1999) 0.88